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ABSTRACT
Human listeriosis is caused by the Gram-positive bacterium Listeria monocytogenes. In humans, this
pathogen has the ability to cross the intestinal, placental and blood–brain barriers, leading to
gastroenteritis, maternofetal infections and meningoencephalitis, respectively. The entry of L. mono-
cytogenes into cultured human epithelial cells is mediated by the interaction of an L. monocytogenes
surface protein, internalin, with its human receptor, E-cadherin. The internalin–E-cadherin interaction
is species-speciﬁc, and relies on the nature of a single amino-acid in the E-cadherin molecule, which
is proline in permissive species such as humans, and glutamic acid in non-permissive species such
as the mouse. In a transgenic mouse model that expresses human E-cadherin in enterocytes,
internalin allows L. monocytogenes to cross the intestinal barrier. Epidemiological evidence also
supports a role for internalin in human listeriosis, not only for crossing the intestinal barrier, but
also for targeting and crossing the placental and blood–brain barriers. Consistent with these
epidemiological data, infection with L. monocytogenes of trophoblastic cell lines, primary trophoblast
cultures and human placental villous explants demonstrates that bacterial invasion of the
syncytiotrophoblast barrier is mediated by the internalin–E-cadherin interaction, leading to
histopathological lesions that mimic those seen in the placentas of women with listeriosis. Thus,
the internalin–E-cadherin interaction that plays a key role in the crossing of the intestinal barrier in
humans is also exploited by L. monocytogenes to target and cross the placental barrier. Further
investigations are currently focusing on the molecular mechanisms by which L. monocytogenes targets
and crosses the blood–brain barrier.
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INTRODUCTION
Listeria monocytogenes is a Gram-positive food-
borne pathogen that is responsible for listeriosis,
a human infection with an overall mortality rate
of 30%, which ranges from clinically asympto-
matic faecal carriage to febrile gastroenteritis,
severe mother-to-child infections, and central
nervous system infections [1]. The organism has
the amazing ability to cross three signiﬁcant
barriers in humans, namely the intestinal bar-
rier, the blood–brain barrier and the fetoplacen-
tal barrier. L. monocytogenes is a facultative
intracellular bacterium that has the unusual
capacity to enter, survive and multiply in both
phagocytic and non-phagocytic cells [2]. This
property, which has been studied in detail in
cultured cells, is considered to be central for the
pathophysiology of human listeriosis.
Several L. monocytogenes factors mediating the
key steps in cell infection have been identiﬁed.
These include: (1) internalin (also called InlA)
and InlB (another member of the internalin
multigene family, characterised by the presence
of leucine-rich repeats), which are responsible
for internalisation of L. monocytogenes in cul-
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tured non-phagocytic cells; (2) listeriolysin,
which acts in concert with two phospholipases
(PlcA and PlcB) to allow escape from the
phagocytic vacuole; and (3) ActA, which medi-
ates actin-based intracytoplasmic movement and
cell–cell spreading (Fig. 1) [2].
In mice, intravenous inoculation of L. monocy-
togenes induces dose-dependent lethality. This
infection model has been used successfully for
decades as a model for intracellular bacterial
infections, and played a key role in the discovery
of cell-mediated immunity [3]. In contrast, oral
inoculation is a very inefﬁcient way to trigger
systemic listeriosis, because L. monocytogenes
translocation across the intestinal barrier is inef-
ﬁcient and is similar to that of the closely related
non-pathogenic species Listeria innocua. The few
detectable foci of bacterial multiplication are
restricted to Peyer’s patches, areas that contain
M-cells (i.e., cells possessing phagocytic activity).
Thus, L. monocytogenes is not an enteropathogen
for mice. Moreover, in mice, the brainstem and
the fetoplacental unit do not appear to be elective
targets, as is the case in humans. Following
intravenous inoculation of mice, listeriolysin,
ActA, PlcA and PlcB act as virulence factors. This
is not the case for internalin [2]; indeed, despite
the well-established prominent role of internalin
in the internalisation process in vitro, its role
in vivo has long remained elusive, with an
internalin mutant behaving in the same way as
its wild-type parent after intravenous or oral
inoculation of mice [4].
SPECIES-SPECIFICITY OF THE
INTERNALIN–E-CADHERIN
INTERACTION
Shortly after the discovery, via an afﬁnity chroma-
tography approach, that human E-cadherin was
the internalin receptor in a human epithelial cell
line (Caco-2 cells) [5], it was established that, in
contrast to human E-cadherin, mouse E-cadherin
was unable to promote entry of L. monocytogenes
into cells [4]. This speciﬁcity was shown to depend
on the nature of a single amino-acid, the sixteenth,
in the mature E-cadherin peptide chain, which is
proline in permissive species (humans, guinea-
pigs, ovines, bovines) and glutamic acid in non-
permissive species (mice, rats) (Fig. 2a) [4].
Replacement of this glutamic acid with proline
leads to a gain in function, thereby establishing the
critical role of this residue in the internalin–
E-cadherin interaction [4]. Determination of the
crystal structures of the functional domain of
internalin alone, and in a complex with the extra-
cellular N-terminal domain of human E-cadherin,
demonstrated that proline-16 is involved directly
in the internalin–E-cadherin interaction and is
essential for inter-molecular recognition [6]. This
result led to the conclusion that L. monocytogenes
exhibits a stringent species-speciﬁcity towards its
host, and that the mouse model was inappropriate
for the study of internalin function [4].
ROLE OF THE INTERNALIN–
E-CADHERIN INTERACTION IN
CROSSING OF THE INTESTINAL
BARRIER
In a search for a more appropriate animal species
in which to study the putative role of the
internalin interaction with E-cadherin in vivo,
cultured guinea-pig epithelial cells were shown
to allow internalin-dependent entry of L. monocy-
togenes and to express E-cadherin with a proline at
position 16 (Fig. 2a) [4]. In this small animal
model, contrary to observations in mice and rats
(whose E-cadherin also has a glutamic acid at
position 16, and which are also resistant to oral
infection with Listeria), L. monocytogenes is able to
induce a gastroenteritis resembling that observed
in humans [7,8]. Moreover, it is able to cross the
intestinal barrier and induce a dose- and intern-
alin-dependent lethality following dissemination
to the systemic circulation [9].
Fig. 1. Schematic representation of the process of cellular
infection by Listeria monocytogenes. LLO, listeriolysin; PlcA,
phospholipase A; PlcB, phospholipase B. Adapted with
permission from [2].
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In order to investigate the role of the internalin–
E-cadherin interaction in the ability of L. monocy-
togenes to cross the intestinal barrier, a transgenic
mouse model was designed [9]. The human
E-cadherin cDNA was placed under the control
of the promoter of the intestinal fatty-acid-binding
protein (iFABP) gene, which is active exclusively
in post-mitotic non-proliferative small intestinal
enterocytes (Fig. 2b). In this transgenic model,
L. monocytogenes targets enterocytes directly by
interacting with enterocyte E-cadherin [9]. This
interaction leads to Listeria internalisation into
these cells, and allows subsequent crossing of the
intestinal barrier, followed by bacterial multipli-
cation in the small intestine lamina propria, and
dissemination to mesenteric lymph nodes, liver
and spleen [9]. This is the ﬁrst transgenic model to
reveal the role of a bacterial virulence factor and
to demonstrate its critical involvement in a key
step of an infection process [3]. The fact that
expression of human E-cadherin is restricted to
enterocytes has been critical in demonstrating the
direct in-vivo targeting of enterocytes by L. mono-
cytogenes at the molecular level, and its genuine
enteropathogenicity. Furthermore, this transgenic
model provides a molecular explanation for the
lack of pathogenicity of L. monocytogenes in mice
following oral infection, and also explains the
enteropathogenicity of L. monocytogenes in guinea-
pigs and, most probably, in humans.
In contrast to non-transgenic mice, transgenic
mice expressing human E-cadherin are highly
permissive to listeriosis acquired orally, thereby
demonstrating an essential role for internalin in
the ability of L. monocytogenes to cross the
intestinal barrier. Thus, a mouse model for
listeriosis acquired orally is now available, in
which the host response to listeriosis can be
studied in depth from its starting point (i.e., the
intestinal lumen), using the combined approa-
ches of microbial genetics, transgenesis, gnoto-
biology and functional genomics coupled to
laser capture microdissection, as described pre-
viously for studies of the host response to
commensal bacteria [10,11]. The availability of
the L. monocytogenes genome sequence, together
with that of its non-pathogenic counterpart
L. innocua, will probably be very helpful in
identifying additional virulence factors in con-
junction with this new model [12,13].
Fig. 2. (a) In-vivo consequences of the species-speciﬁc interaction of internalin with E-cadherin. The successive steps of
human listeriosis are shown on the left. The internalin–E-cadherin interaction is critical for L. monocytogenes entry into
enterocytes and syncytiotrophoblasts, and thus for the crossing of the intestinal and placental barriers in vivo. The putative
role of the internalin–E-cadherin interaction in the crossing of the blood–brain barrier has not yet been tested. (b) Small-
intestine sections of an iFABP–hEcad transgenic mouse (left) and a non-transgenic littermate (right), immunolabelled with
anti-hEcad HECD1 mouse monoclonal antibody (red). HECD1 recognises human, but not mouse E-cadherin. The
background signal in the lamina propria is caused by the reactivity of the secondary goat anti-mouse IgG antibody towards
endogenous mouse IgG. A cross-section of a transgenic intestinal epithelial sheet allows detection of the typical
honeycomb-like pattern of E-cadherin labelling. Scale bar = 10 lm. (c) Listeria monocytogenes multiplication within the
lamina propria of a small-intestine villus of an iFABP–hEcad transgenic mouse 48 h after intragastric inoculation. A small-
intestine section of an iFABP–hEcad transgenic mouse infected orally with L. monocytogenes and immunolabelled with
rabbit anti-L. monocytogenes R11 polyclonal antibody (red). L. monocytogenes cells have crossed the intestinal barrier and
replicate in the lamina propria, a phenomenon that is never observed in non-transgenic mice. Scale bar = 10 lm. Adapted
with permission from [3].
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However, this system also has its limitations,
which were anticipated when the transgenesis
strategy was designed [3]. Indeed, because
human E-cadherin expression is restricted to
enterocytes in the iFABP–hEcad transgenic mice,
the role of E-cadherin expressed on cell types
other than enterocytes-such as dendritic cells,
hepatocytes, microvascular endothelial cells, epi-
thelial cells of the choroid plexus, and cyto
trophoblastic cells, which are all putative
L. monocytogenes targets during human listerio-
sis-cannot be studied. Transgenic mice that over-
come this limitation are now being generated by
modifying, at the endogenous mouse E-cadherin
locus Cdh1 on mouse chromosome 8, the codon
for mouse E-cadherin glutamic acid 16 into a
codon for proline. This unique change in murine
E-cadherin has been shown to be sufﬁcient to
convert mouse E-cadherin into an internalin
receptor in transfected cultured cells expressing
this modiﬁed Glu16Pro mouse E-cadherin [4].
The new transgenic mouse line should permit the
study of the tropism of L. monocytogenes for the
central nervous system and the fetoplacental unit,
which is responsible for the lethality of human
listeriosis, and further investigations of the role of
the internalin–E-cadherin interaction in extra-
intestinal tissues.
EPIDEMIOLOGICAL
DEMONSTRATION OF THE ROLE OF
INTERNALIN IN HUMANS
In order to validate the contribution of intern-
alin in humans, an epidemiological approach
has been adopted [14]. Isolates of L. monocyto-
genes exist that express a truncated form of
internalin, which is no longer anchored to the
surface of the bacteria and is thus non-func-
tional. In-vitro, such isolates enter cultured
human intestinal cells very inefﬁciently and
behave as an internalin gene deletion mutant.
An epidemiological study determined the
respective frequencies of isolates expressing a
full-length or a truncated internalin within two
sets of isolates, of food and clinical origin,
respectively, that were collected prospectively
over the course of 1 year by the French National
Reference Centre for Listeriosis (Institut Pasteur,
Paris) [14]. The working hypothesis was that
there would be a higher frequency of isolates
expressing a functional internalin among the
isolates of clinical origin than among the isolates
of food origin, and that this would constitute an
epidemiological demonstration of the role of
internalin in human listeriosis. This assumption
was conﬁrmed without ambiguity. Indeed, of
300 clinical isolates studied, 96% expressed a
wild-type full-length internalin, compared with
only 65% of the 150 isolates of food origin
(p < 10)7; OR 12.73; 95% CI 6.27–26.34) [14].
Moreover, all the isolates responsible for feto-
placental infections (61 ⁄ 61), and all but one of
those responsible for infections of the central
nervous system (55 ⁄ 56), expressed a wild-type
full-length internalin. These results not only
demonstrated the crucial role of internalin in
human listeriosis, but also suggested that it is
implicated in crossing of the fetoplacental bar-
rier and the blood–brain barrier. Moreover, all
110 isolates belonging to serovar 4b, the serovar
implicated most frequently in human listeriosis,
expressed full-length internalin, providing a
molecular explanation for the predominance of
serovar 4b among clinical isolates. Overall, these
epidemiological results supported the usefulness
of studies on the expression of internalin as an
indication for L. monocytogenes virulence in
humans [14].
ROLE OF THE INTERNALIN–
E-CADHERIN INTERACTION IN
CROSSING OF THE PLACENTAL
BARRIER
The above epidemiological ﬁndings, the species-
speciﬁcity of the internalin–E-cadherin interac-
tion, and the absence of a transgenic mouse model
in which human E-cadherin is expressed in all
epithelial lineages, prompted a direct examination
of the role of the internalin–E-cadherin interaction
in crossing of the maternofetal barrier in humans.
This was done by means of immunohistopatho-
logical studies of placentas from women with
listeriosis, in conjunction with the use of human
primary trophoblasts and placental explants [15].
The human maternofetal barrier contains two
anatomically distinct components, namely the
chorioallantoic placenta and the chorioamnion.
The barrier is formed at the placental level by
the villous syncytiotrophoblast (Fig. 3). This
specialised epithelial lineage is in direct con-
tact with maternal blood circulating through
the intervillous space. In a subjacent layer,
Lecuit Listeria monocytogenes and host barriers 433
 2005 Copyright by the European Society of Clinical Microbiology and Infectious Diseases, CMI, 11, 430–436
mononuclear cytotrophoblasts divide, differenti-
ate and fuse to renew overlying multinucleated
syncytiotrophoblasts. A basement membrane
separates these trophoblastic cells from a con-
nective tissue core that contains fetal capillaries.
The amniotic epithelium forms the maternofetal
interface in the chorioamnion. The apical surface
of this epithelium is exposed to amniotic ﬂuid,
whereas its basal surface sits on a basement
membrane that overlies the amniotic mesoderm.
Immunohistochemical studies of multiple sec-
tions prepared from each placenta revealed
blood-borne bacteria in the intervillous spaces.
Bacteria were also detected on the surfaces of
syncytiotrophoblasts and cytotrophoblasts, in
the cytoplasm of syncytiotrophoblasts, and in
the villous core adjacent to fetal capillaries.
Isolated villi and villous clusters contained foci
of bacteria forming abscesses. Bacteria were also
detected on and in amniotic epithelial cells, but
were not apparent in the connective tissue of
the subjacent chorion that overlies the maternal
decidua. These ﬁndings suggested that L. mono-
cytogenes infection of the human fetoplacental
unit follows a transplacental route. They also
suggested a testable hypothesis, namely that
extracellular bacteria present in the maternal
blood that bathes placental villi can recognise
and bind to a speciﬁc surface receptor, leading
to penetration of the syncytiotrophoblast layer
and subsequent invasion of the fetal vascular
compartment in the villous core.
Investigation of the cellular patterns of expres-
sion of internalin receptor E-cadherin at the
maternofetal interface demonstrated that it is
expressed on the basal and apical plasma mem-
branes of syncytiotrophoblasts (Fig. 4a). Quanti-
tative assays of cellular invasion in trophoblastic
cell lines (Fig. 4b), primary trophoblast cultures
and placental villous explants (Fig. 4c) demon-
strated that bacterial entry into syncytiotropho-
blasts occurs via the apical membrane in an
internalin–E-cadherin-dependent manner. In
human placental villous explants, bacterial inva-
sion of the syncytiotrophoblast barrier and under-
lying villous tissue, and subsequent replication,
produces histopathological lesions that mimic
those seen in placentas from women with listeri-
osis (Fig. 4d). Thus, the internalin–E-cadherin
interaction, which plays a key role in the crossing
of the intestinal barrier, is also exploited by
L. monocytogenes to target and cross the human
placental barrier [15].
CONCLUSIONS
The studies described above show that L. mono-
cytogenes uses a common strategy to recognise
Fig. 3. Anatomy of the maternofetal interface in humans. (a) View of a pregnant human uterus. (b) Expanded view of a
small segment of the placental villous tree. A cross-section of a villus with an associated diagrammatic outline of the
histology (c) reveals a relatively empty intervillous space surrounding a villus in cross-section. This space is normally ﬁlled
with maternal blood. The multinucleated syncytiotrophoblast, a true syncytium without lateral cell membranes, covers the
villi and an underlying discontinuous layer of cytotrophoblasts in the second half of pregnancy. The subjacent
cytotrophoblasts are mitotically active and, through a process of differentiation and fusion, give rise to more syncytium.
The two villous trophoblast cell types share a basement membrane that delimits the villous core connective tissue where
fetal vessels pass. The placental ‘barrier’ in the villous tree thus includes the apical microvillous surface membrane of the
syncytiotrophoblast, the basal surface membrane of the syncytiotrophoblast, the trophoblastic basement membrane, and
the villous core connective tissues.
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and cross the intestinal and placental barriers.
This raises the possibility that L. monocytogenes
placental tropism may be a consequence of its
evolved mechanism for targeting the intestinal
epithelium. The results also show that, in addition
to pregnancy-associated immunosuppression, a
speciﬁc mechanism allows L. monocytogenes to
directly target and invade the human placental
barrier. Interestingly, the blood–brain barrier is
also composed of E-cadherin-expressing cells, the
microvascular endothelium and choroid plexus
epithelium. Thus, it is tempting to speculate that
targeting and invasion of the central nervous
system by L. monocytogenes may also be mediated
by the interaction between internalin and
E-cadherin. Other human pathogens, such as
Toxoplasma gondii or human cytomegalovirus,
exhibit a similar tropism for these three barriers.
Future studies focused on deciphering the simi-
larities and speciﬁcities of these barriers may
extend our understanding of the strategies that
microbes use to breach them.
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Fig. 4. (a) Section of a human placental villus centred on
the syncytiotrophoblast and immunolabelled with an
antibody directed against human E-cadherin. E-cadherin
appears in green and nuclei in blue. (b) Adhesion and
invasion of bacteria expressing internalin in cultured
human syncytiotrophoblast. Bacteria are shown in red,
E-cadherin in green, and nuclei in blue. There is a
recruitment of E-cadherin to the site of entry of the
bacteria in the syncytiotrophoblast. (c) Section of a placen-
tal villus infected ex vivo. L. monocytogenes has invaded the
syncytiotrophoblast and crossed the placental barrier. This
has led to the constitution of villous microabscesses similar
to those observed within placentas obtained from pregnant
women with listeriosis (d). Bacteria are shown in purple in
(c) and in red in (d).
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